ESYT1_HUMAN - dbPTM
ESYT1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ESYT1_HUMAN
UniProt AC Q9BSJ8
Protein Name Extended synaptotagmin-1
Gene Name ESYT1
Organism Homo sapiens (Human).
Sequence Length 1104
Subcellular Localization Endoplasmic reticulum membrane
Multi-pass membrane protein. Cell membrane
Peripheral membrane protein. Localizes primarily to the endoplasmic reticulum. Recruited to sites of contact between the endoplasmic reticulum and the cell membrane in respon
Protein Description Binds glycerophospholipids in a barrel-like domain and may play a role in cellular lipid transport (By similarity). Binds calcium (via the C2 domains) and translocates to sites of contact between the endoplasmic reticulum and the cell membrane in response to increased cytosolic calcium levels. Helps tether the endoplasmic reticulum to the cell membrane and promotes the formation of appositions between the endoplasmic reticulum and the cell membrane..
Protein Sequence MERSPGEGPSPSPMDQPSAPSDPTDQPPAAHAKPDPGSGGQPAGPGAAGEALAVLTSFGRRLLVLIPVYLAGAVGLSVGFVLFGLALYLGWRRVRDEKERSLRAARQLLDDEEQLTAKTLYMSHRELPAWVSFPDVEKAEWLNKIVAQVWPFLGQYMEKLLAETVAPAVRGSNPHLQTFTFTRVELGEKPLRIIGVKVHPGQRKEQILLDLNISYVGDVQIDVEVKKYFCKAGVKGMQLHGVLRVILEPLIGDLPFVGAVSMFFIRRPTLDINWTGMTNLLDIPGLSSLSDTMIMDSIAAFLVLPNRLLVPLVPDLQDVAQLRSPLPRGIIRIHLLAARGLSSKDKYVKGLIEGKSDPYALVRLGTQTFCSRVIDEELNPQWGETYEVMVHEVPGQEIEVEVFDKDPDKDDFLGRMKLDVGKVLQASVLDDWFPLQGGQGQVHLRLEWLSLLSDAEKLEQVLQWNWGVSSRPDPPSAAILVVYLDRAQDLPLKKGNKEPNPMVQLSIQDVTQESKAVYSTNCPVWEEAFRFFLQDPQSQELDVQVKDDSRALTLGALTLPLARLLTAPELILDQWFQLSSSGPNSRLYMKLVMRILYLDSSEICFPTVPGCPGAWDVDSENPQRGSSVDAPPRPCHTTPDSQFGTEHVLRIHVLEAQDLIAKDRFLGGLVKGKSDPYVKLKLAGRSFRSHVVREDLNPRWNEVFEVIVTSVPGQELEVEVFDKDLDKDDFLGRCKVRLTTVLNSGFLDEWLTLEDVPSGRLHLRLERLTPRPTAAELEEVLQVNSLIQTQKSAELAAALLSIYMERAEDLPLRKGTKHLSPYATLTVGDSSHKTKTISQTSAPVWDESASFLIRKPHTESLELQVRGEGTGVLGSLSLPLSELLVADQLCLDRWFTLSSGQGQVLLRAQLGILVSQHSGVEAHSHSYSHSSSSLSEEPELSGGPPHITSSAPELRQRLTHVDSPLEAPAGPLGQVKLTLWYYSEERKLVSIVHGCRSLRQNGRDPPDPYVSLLLLPDKNRGTKRRTSQKKRTLSPEFNERFEWELPLDEAQRRKLDVSVKSNSSFMSRERELLGKVQLDLAETDLSQGVARWYDLMDNKDKGSS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MERSPGEG
-------CCCCCCCC
42.2619413330
4Phosphorylation----MERSPGEGPSP
----CCCCCCCCCCC
40.3123663014
10PhosphorylationRSPGEGPSPSPMDQP
CCCCCCCCCCCCCCC
49.1923663014
12PhosphorylationPGEGPSPSPMDQPSA
CCCCCCCCCCCCCCC
36.8723663014
18PhosphorylationPSPMDQPSAPSDPTD
CCCCCCCCCCCCCCC
47.3723312004
24O-linked_GlycosylationPSAPSDPTDQPPAAH
CCCCCCCCCCCCCCC
52.86OGP
77PhosphorylationLAGAVGLSVGFVLFG
HHHHHHHHHHHHHHH
17.79-
88PhosphorylationVLFGLALYLGWRRVR
HHHHHHHHHCHHHHH
9.5030576142
116PhosphorylationLDDEEQLTAKTLYMS
CCCHHHHHHHHHHHH
26.2928857561
118UbiquitinationDEEQLTAKTLYMSHR
CHHHHHHHHHHHHHC
33.5521890473
118 (in isoform 2)Ubiquitination-33.5521890473
118 (in isoform 1)Ubiquitination-33.5521890473
119PhosphorylationEEQLTAKTLYMSHRE
HHHHHHHHHHHHHCC
22.2123090842
121PhosphorylationQLTAKTLYMSHRELP
HHHHHHHHHHHCCCC
11.2125884760
123PhosphorylationTAKTLYMSHRELPAW
HHHHHHHHHCCCCCC
13.0623090842
132PhosphorylationRELPAWVSFPDVEKA
CCCCCCCCCCCHHHH
21.9928857561
138UbiquitinationVSFPDVEKAEWLNKI
CCCCCHHHHHHHHHH
51.9921890473
138 (in isoform 2)Ubiquitination-51.9921890473
138AcetylationVSFPDVEKAEWLNKI
CCCCCHHHHHHHHHH
51.9926822725
138 (in isoform 1)Ubiquitination-51.9921890473
170MethylationETVAPAVRGSNPHLQ
HHHHHHHCCCCCCCE
44.95-
172PhosphorylationVAPAVRGSNPHLQTF
HHHHHCCCCCCCEEE
36.3029978859
178PhosphorylationGSNPHLQTFTFTRVE
CCCCCCEEEEEEEEE
30.8827067055
180PhosphorylationNPHLQTFTFTRVELG
CCCCEEEEEEEEEEC
27.7327067055
182PhosphorylationHLQTFTFTRVELGEK
CCEEEEEEEEEECCC
30.6527067055
189AcetylationTRVELGEKPLRIIGV
EEEEECCCCEEEEEE
47.7823749302
189UbiquitinationTRVELGEKPLRIIGV
EEEEECCCCEEEEEE
47.781890473
189 (in isoform 2)Ubiquitination-47.7821890473
189 (in isoform 1)Ubiquitination-47.7821890473
197UbiquitinationPLRIIGVKVHPGQRK
CEEEEEEEECCCCCH
29.6121890473
197 (in isoform 2)Ubiquitination-29.6121890473
197MalonylationPLRIIGVKVHPGQRK
CEEEEEEEECCCCCH
29.6126320211
197AcetylationPLRIIGVKVHPGQRK
CEEEEEEEECCCCCH
29.6125953088
197 (in isoform 1)Ubiquitination-29.6121890473
231UbiquitinationEVKKYFCKAGVKGMQ
EHHHHHHHHCCCHHC
37.97-
235MalonylationYFCKAGVKGMQLHGV
HHHHHCCCHHCHHHH
47.9826320211
269PhosphorylationMFFIRRPTLDINWTG
EEEECCCCCCCCCCC
34.94-
324PhosphorylationQDVAQLRSPLPRGII
HHHHHHCCCCCCHHH
39.1025849741
344UbiquitinationAARGLSSKDKYVKGL
HHCCCCCCCHHHHHH
55.66-
347PhosphorylationGLSSKDKYVKGLIEG
CCCCCCHHHHHHCCC
19.9629978859
349UbiquitinationSSKDKYVKGLIEGKS
CCCCHHHHHHCCCCC
44.93-
349 (in isoform 2)Ubiquitination-44.93-
355UbiquitinationVKGLIEGKSDPYALV
HHHHCCCCCCCCHHH
38.6121906983
355 (in isoform 2)Ubiquitination-38.6121890473
355MalonylationVKGLIEGKSDPYALV
HHHHCCCCCCCCHHH
38.6132601280
355 (in isoform 1)Ubiquitination-38.6121890473
356PhosphorylationKGLIEGKSDPYALVR
HHHCCCCCCCCHHHE
55.4620860994
359PhosphorylationIEGKSDPYALVRLGT
CCCCCCCCHHHEECC
19.9825884760
366PhosphorylationYALVRLGTQTFCSRV
CHHHEECCCCHHHHH
29.0926471730
371PhosphorylationLGTQTFCSRVIDEEL
ECCCCHHHHHCCCCC
25.9526471730
409UbiquitinationVFDKDPDKDDFLGRM
EECCCCCCCCCCCCC
65.66-
417UbiquitinationDDFLGRMKLDVGKVL
CCCCCCCCCCHHHHH
39.93-
417AcetylationDDFLGRMKLDVGKVL
CCCCCCCCCCHHHHH
39.9325953088
422UbiquitinationRMKLDVGKVLQASVL
CCCCCHHHHHHHHEE
39.35-
422 (in isoform 2)Ubiquitination-39.35-
453PhosphorylationLEWLSLLSDAEKLEQ
HHHHHHHCCHHHHHH
39.82-
493UbiquitinationRAQDLPLKKGNKEPN
HHHCCCCCCCCCCCC
57.61-
493MalonylationRAQDLPLKKGNKEPN
HHHCCCCCCCCCCCC
57.6126320211
493AcetylationRAQDLPLKKGNKEPN
HHHCCCCCCCCCCCC
57.6125953088
494 (in isoform 2)Phosphorylation-75.33-
495 (in isoform 2)Phosphorylation-49.18-
497UbiquitinationLPLKKGNKEPNPMVQ
CCCCCCCCCCCCCEE
81.08-
497MalonylationLPLKKGNKEPNPMVQ
CCCCCCCCCCCCCEE
81.0826320211
497 (in isoform 1)Ubiquitination-81.0821890473
498 (in isoform 2)Phosphorylation-55.07-
506PhosphorylationPNPMVQLSIQDVTQE
CCCCEEEEEEECHHH
10.9127251275
507 (in isoform 2)Ubiquitination-5.7221890473
511PhosphorylationQLSIQDVTQESKAVY
EEEEEECHHHHHHHH
34.60-
514PhosphorylationIQDVTQESKAVYSTN
EEECHHHHHHHHCCC
18.9827251275
546UbiquitinationQELDVQVKDDSRALT
CCCCEEECCCHHHHH
38.4321906983
546 (in isoform 1)Ubiquitination-38.4321890473
553PhosphorylationKDDSRALTLGALTLP
CCCHHHHHHHHHHHH
23.3527050516
556 (in isoform 2)Ubiquitination-10.6521890473
580PhosphorylationDQWFQLSSSGPNSRL
HHHHHHCCCCCCHHH
48.16-
588PhosphorylationSGPNSRLYMKLVMRI
CCCCHHHHHHHHHHH
7.35-
626PhosphorylationSENPQRGSSVDAPPR
CCCCCCCCCCCCCCC
29.4023927012
627PhosphorylationENPQRGSSVDAPPRP
CCCCCCCCCCCCCCC
27.1723401153
635S-palmitoylationVDAPPRPCHTTPDSQ
CCCCCCCCCCCCCHH
4.7421044946
637PhosphorylationAPPRPCHTTPDSQFG
CCCCCCCCCCCHHCC
46.9023927012
637O-linked_GlycosylationAPPRPCHTTPDSQFG
CCCCCCCCCCCHHCC
46.90OGP
638PhosphorylationPPRPCHTTPDSQFGT
CCCCCCCCCCHHCCC
11.0528464451
641PhosphorylationPCHTTPDSQFGTEHV
CCCCCCCHHCCCCCE
28.7223927012
645PhosphorylationTPDSQFGTEHVLRIH
CCCHHCCCCCEEEEE
24.9823927012
662UbiquitinationEAQDLIAKDRFLGGL
EHHHHHHCCCCCCHH
42.30-
671UbiquitinationRFLGGLVKGKSDPYV
CCCCHHCCCCCCCCC
66.71-
673UbiquitinationLGGLVKGKSDPYVKL
CCHHCCCCCCCCCEE
46.07-
674PhosphorylationGGLVKGKSDPYVKLK
CHHCCCCCCCCCEEE
53.1128152594
677PhosphorylationVKGKSDPYVKLKLAG
CCCCCCCCCEEEECC
18.4028152594
679AcetylationGKSDPYVKLKLAGRS
CCCCCCCEEEECCCC
33.7819608861
679UbiquitinationGKSDPYVKLKLAGRS
CCCCCCCEEEECCCC
33.7819608861
679MalonylationGKSDPYVKLKLAGRS
CCCCCCCEEEECCCC
33.7832601280
681 (in isoform 2)Ubiquitination-30.49-
681UbiquitinationSDPYVKLKLAGRSFR
CCCCCEEEECCCCHH
30.49-
686PhosphorylationKLKLAGRSFRSHVVR
EEEECCCCHHHHCHH
24.8830266825
727UbiquitinationVFDKDLDKDDFLGRC
EECCCCCCCCCHHCC
67.50-
739PhosphorylationGRCKVRLTTVLNSGF
HCCEEEEEEEECCCC
12.3221130716
740PhosphorylationRCKVRLTTVLNSGFL
CCEEEEEEEECCCCC
27.8221130716
744PhosphorylationRLTTVLNSGFLDEWL
EEEEEECCCCCCCCE
27.1021130716
817AcetylationLPLRKGTKHLSPYAT
CCCCCCCCCCCCCCE
51.7419608861
817UbiquitinationLPLRKGTKHLSPYAT
CCCCCCCCCCCCCCE
51.7421890473
817 (in isoform 1)Ubiquitination-51.7421890473
820PhosphorylationRKGTKHLSPYATLTV
CCCCCCCCCCCEEEE
18.6529255136
822PhosphorylationGTKHLSPYATLTVGD
CCCCCCCCCEEEECC
14.6125159151
824PhosphorylationKHLSPYATLTVGDSS
CCCCCCCEEEECCCC
19.6730266825
826PhosphorylationLSPYATLTVGDSSHK
CCCCCEEEECCCCCC
20.3530266825
827 (in isoform 2)Ubiquitination-10.1121890473
830PhosphorylationATLTVGDSSHKTKTI
CEEEECCCCCCCCEE
28.5423927012
831PhosphorylationTLTVGDSSHKTKTIS
EEEECCCCCCCCEEE
33.4723927012
833UbiquitinationTVGDSSHKTKTISQT
EECCCCCCCCEEECC
54.38-
833MalonylationTVGDSSHKTKTISQT
EECCCCCCCCEEECC
54.3826320211
834PhosphorylationVGDSSHKTKTISQTS
ECCCCCCCCEEECCC
28.1720068231
835UbiquitinationGDSSHKTKTISQTSA
CCCCCCCCEEECCCC
48.9821906983
835 (in isoform 1)Ubiquitination-48.9821890473
836PhosphorylationDSSHKTKTISQTSAP
CCCCCCCEEECCCCC
30.9620068231
838PhosphorylationSHKTKTISQTSAPVW
CCCCCEEECCCCCCC
32.4120068231
840PhosphorylationKTKTISQTSAPVWDE
CCCEEECCCCCCCCC
21.7720068231
841PhosphorylationTKTISQTSAPVWDES
CCEEECCCCCCCCCC
23.9620068231
845 (in isoform 2)Ubiquitination-11.5521890473
848PhosphorylationSAPVWDESASFLIRK
CCCCCCCCCCEEEEC
27.0920068231
850PhosphorylationPVWDESASFLIRKPH
CCCCCCCCEEEECCC
29.8428857561
855UbiquitinationSASFLIRKPHTESLE
CCCEEEECCCCCCEE
33.8721906983
855 (in isoform 1)Ubiquitination-33.8721890473
858PhosphorylationFLIRKPHTESLELQV
EEEECCCCCCEEEEE
35.4826471730
860PhosphorylationIRKPHTESLELQVRG
EECCCCCCEEEEEEC
28.4420873877
865 (in isoform 2)Ubiquitination-15.4221890473
896PhosphorylationLCLDRWFTLSSGQGQ
HHHCCEEECCCCCCH
20.8325850435
924PhosphorylationHSGVEAHSHSYSHSS
CCCCCEECCCCCCCC
22.6028348404
926PhosphorylationGVEAHSHSYSHSSSS
CCCEECCCCCCCCCC
31.2028348404
927PhosphorylationVEAHSHSYSHSSSSL
CCEECCCCCCCCCCC
12.6528348404
928PhosphorylationEAHSHSYSHSSSSLS
CEECCCCCCCCCCCC
21.6528348404
930PhosphorylationHSHSYSHSSSSLSEE
ECCCCCCCCCCCCCC
26.4426657352
931PhosphorylationSHSYSHSSSSLSEEP
CCCCCCCCCCCCCCC
20.6526657352
932PhosphorylationHSYSHSSSSLSEEPE
CCCCCCCCCCCCCCH
38.0128348404
933PhosphorylationSYSHSSSSLSEEPEL
CCCCCCCCCCCCCHH
37.5526657352
935PhosphorylationSHSSSSLSEEPELSG
CCCCCCCCCCCHHHC
41.6926657352
941PhosphorylationLSEEPELSGGPPHIT
CCCCCHHHCCCCCCC
39.7928464451
948PhosphorylationSGGPPHITSSAPELR
HCCCCCCCCCCHHHH
17.3726657352
949PhosphorylationGGPPHITSSAPELRQ
CCCCCCCCCCHHHHH
24.7326074081
950PhosphorylationGPPHITSSAPELRQR
CCCCCCCCCHHHHHH
38.9126074081
959PhosphorylationPELRQRLTHVDSPLE
HHHHHHHHCCCCCCC
23.2630266825
963PhosphorylationQRLTHVDSPLEAPAG
HHHHCCCCCCCCCCC
30.2329255136
981PhosphorylationQVKLTLWYYSEERKL
EEEEEEEEEECCHHH
10.54-
982PhosphorylationVKLTLWYYSEERKLV
EEEEEEEEECCHHHH
9.68-
987UbiquitinationWYYSEERKLVSIVHG
EEEECCHHHHHHHHH
57.42-
997 (in isoform 2)Ubiquitination-31.79-
1009PhosphorylationGRDPPDPYVSLLLLP
CCCCCCCCEEEEECC
15.2821082442
1011PhosphorylationDPPDPYVSLLLLPDK
CCCCCCEEEEECCCC
13.8825849741
1011O-linked_GlycosylationDPPDPYVSLLLLPDK
CCCCCCEEEEECCCC
13.8823301498
1018UbiquitinationSLLLLPDKNRGTKRR
EEEECCCCCCCCCCC
46.75-
1022PhosphorylationLPDKNRGTKRRTSQK
CCCCCCCCCCCCCCC
20.38-
1032PhosphorylationRTSQKKRTLSPEFNE
CCCCCCCCCCHHHHH
40.2330266825
1034PhosphorylationSQKKRTLSPEFNERF
CCCCCCCCHHHHHHC
23.0519664994
1054UbiquitinationLDEAQRRKLDVSVKS
CCHHHHHCCCEECCC
51.75-
1054MalonylationLDEAQRRKLDVSVKS
CCHHHHHCCCEECCC
51.7526320211
1058PhosphorylationQRRKLDVSVKSNSSF
HHHCCCEECCCCCCC
24.4020860994
1060UbiquitinationRKLDVSVKSNSSFMS
HCCCEECCCCCCCHH
36.092190698
1060 (in isoform 1)Ubiquitination-36.0921890473
1061PhosphorylationKLDVSVKSNSSFMSR
CCCEECCCCCCCHHH
39.5323312004
1063PhosphorylationDVSVKSNSSFMSRER
CEECCCCCCCHHHHH
31.8520044836
1064PhosphorylationVSVKSNSSFMSRERE
EECCCCCCCHHHHHH
29.2623663014
1067PhosphorylationKSNSSFMSRERELLG
CCCCCCHHHHHHHHC
29.0423663014
1070 (in isoform 2)Ubiquitination-38.4621890473
1075UbiquitinationRERELLGKVQLDLAE
HHHHHHCCEEHHHHH
27.12-
1083PhosphorylationVQLDLAETDLSQGVA
EEHHHHHCCHHHHHH
36.3129507054
1093PhosphorylationSQGVARWYDLMDNKD
HHHHHHHHHHHCCCC
8.1428796482
1099UbiquitinationWYDLMDNKDKGSS--
HHHHHCCCCCCCC--
57.46-
1103PhosphorylationMDNKDKGSS------
HCCCCCCCC------
38.3223401153
1104PhosphorylationDNKDKGSS-------
CCCCCCCC-------
53.5623927012

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
324SPhosphorylationKinaseCDK5Q00535
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ESYT1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ESYT1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
MYH10_HUMANMYH10physical
22939629
SFXN3_HUMANSFXN3physical
22939629
SYJ2B_HUMANSYNJ2BPphysical
22119785
ESYT2_HUMANESYT2physical
22119785
PRAF3_HUMANARL6IP5physical
22119785
YIF1B_HUMANYIF1Bphysical
22119785
TMX1_HUMANTMX1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ESYT1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-817, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1034, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-963 AND SER-1034, ANDMASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-963, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-822, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-822 AND TYR-1009, ANDMASS SPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-822 AND TYR-1009, ANDMASS SPECTROMETRY.

TOP